Depletion of SAT1 or pharmacological inhibition of the transcriptional regulator SP1 using mithramycin in orthotopic tumour mouse models diminishes stromal cell-induced metabolic reprogramming and tumour burden (Fig. 7k). This evidence concerns the gene SAT1 and neoplasm.